Paracoccidioidomycosis is a neglected disease that causes economic and social impacts, mainly affecting people of certain social segments, such as rural workers. The limitations of antifungals, such as toxicity, drug interactions, restricted routes of administration, and the reduced bioavailability in target tissues, have become evident in clinical settings. These factors, added to the fact that Paracoccidioidomycosis (PCM) therapy is a long process, lasting from months to years, emphasize the need for the research and development of new molecules. Researchers have concentrated efforts on the identification of new compounds using numerous tools and targeting important proteins from Paracoccidioides, with the emphasis on enzymatic pathways absent in humans. This review aims to discuss the aspects related to the identification of compounds, methodologies, and perspectives when proposing new antifungal agents against PCM.
Aims: Considering the need to identify new compounds with antifungal action, the activity of five 3-phenacylideneoxindoles compounds was evaluated. Materials & methods: The compounds were synthesiz... Plain language summary Patients affected by paracoccidioidomycosis (PCM) require long-term treatment, which commonly influences their adherence. In addition, only three drugs are in clinical use, w...
Paracoccidioidomycosis (PCM) is a serious system fungal infection that causes significant death and suffering, particularly in Latin America. The treatment of PCM is limited by a few pharmacological options that require long-term administration protocols. Considering the few classes of drugs available for the treatment of PCM and the long time of the treatment, developing new anti-PCM compounds is relevant. With the purpose to develop new 4-methoxynaphthalene-N-acylhydrazone bioisosteres with anti-Paracoccidioides activity, a series of 4-methoxynaphthalene-N-acylhydrazones, which had already been tested against P. brasiliensis, was used to develop shape-based models. The models underwent statistical validation and were used to filter a library of compounds, which were ranked using scoring functions. Molecular docking analysis was used to select 6 compounds that were synthesized and evaluated biologically using minimum inhibitory concentration, minimum fungicidal concentration tests, and cytotoxicity. Using this protocol, we prioritized 6 compounds for synthesis and in vitro biological evaluation. Among them, two compounds (AOS2 and AOS3) were found to exhibit nanomolar activity against two P. brasiliensis isolates and low cytotoxicity for BalbC/3T3 cells (selectivity indexes >2048). The designed and synthesized 4-methoxynaphthalene-N-acylhydrazones could serve as a promising starting point for the development of anti-PCM agents.
Aims: The development of safe and effective therapies for treating paracoccidioidomycosis using computational strategies were employed to discover anti-Paracoccidioides compounds. Materials & metho... Graphical abstract